ResMed Inc. logo

ResMed Inc. (RME)

Market Closed
8 Aug, 20:00
XHAN XHAN
242. 10
+1.3
+0.54%
- Market Cap
27.49 P/E Ratio
1.92% Div Yield
0 Volume
6.52 Eps
240.8
Previous Close
Day Range
239.6 242.1
Year Range
181.75 250.6
Want to track RME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days

Summary

RME closed Friday higher at €242.1, an increase of 0.54% from Thursday's close, completing a monthly increase of 11.21% or €24.4. Over the past 12 months, RME stock gained 9.45%.
RME pays dividends to its shareholders, with the most recent payment made on Jun 12, 2025. The next announced payment will be in In 1 month on Sep 18, 2025 for a total of €0.6.
The last earnings report, released on Jul 31, 2025, exceeded the consensus estimates by 0.07%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports. The next scheduled earnings report is due on Oct 22, 2025.
ResMed Inc. has completed 4 stock splits, with the recent split occurring on Aug 31, 2010.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).

RME Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 8 hours ago
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb

Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb

RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.

Zacks | 1 week ago
ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

ResMed Inc. (NYSE:RMD ) Q4 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Brett A. Sandercock - Chief Financial Officer Michael J.

Seekingalpha | 1 week ago

ResMed Inc. Dividends

ResMed Inc. logo
RMD In 3 days
Announced
Quarterly
$0.6 Per Share
ResMed Inc. logo
RMD 3 months ago
Paid
Quarterly
$0.53 Per Share
ResMed Inc. logo
RMD 5 months ago
Paid
Quarterly
$0.53 Per Share
ResMed Inc. logo
RMD 9 months ago
Paid
Quarterly
$0.53 Per Share
ResMed Inc. logo
RMD 11 months ago
Paid
Quarterly
$0.53 Per Share

ResMed Inc. Earnings

23 Oct 2025 (In 2 months) Date
2.5
Cons. EPS
-
EPS
22 Oct 2025 (In 2 months) Date
2.47
Cons. EPS
-
EPS
22 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
31 Jul 2025 Date
2.48
Cons. EPS
2.55
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
ResMed Inc. logo
RMD In 3 days
Announced
Quarterly
$0.6 Per Share
ResMed Inc. logo
RMD 3 months ago
Paid
Quarterly
$0.53 Per Share
ResMed Inc. logo
RMD 5 months ago
Paid
Quarterly
$0.53 Per Share
ResMed Inc. logo
RMD 9 months ago
Paid
Quarterly
$0.53 Per Share
ResMed Inc. logo
RMD 11 months ago
Paid
Quarterly
$0.53 Per Share
23 Oct 2025 (In 2 months) Date
2.5
Cons. EPS
-
EPS
22 Oct 2025 (In 2 months) Date
2.47
Cons. EPS
-
EPS
22 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
31 Jul 2025 Date
2.48
Cons. EPS
2.55
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS

ResMed Inc. (RME) FAQ

What is the stock price today?

The current price is €242.10.

On which exchange is it traded?

ResMed Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is RME.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.92%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 2.47.

When is the next earnings date?

The next earnings report will release on Oct 22, 2025.

Has ResMed Inc. ever had a stock split?

ResMed Inc. had 4 splits and the recent split was on Aug 31, 2010.

ResMed Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Michael J. Farrell BE, MBA, SM CEO
XHAN Exchange
US7611521078 ISIN
US Country
9,980 Employees
14 Aug 2025 Last Dividend
31 Aug 2010 Last Split
2 Jun 1995 IPO Date

Overview

ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.

Products and Services

  • Technologies for Respiratory Disorders - ResMed offers an array of products for treating various respiratory disorders, including ventilation devices, diagnostic products, and mask systems for use in hospitals and homes. These products are complemented by headgear, accessories, and dental devices, integrating cutting-edge technology for both medical and consumer applications.
  • Cloud-Based Software Informatics - The company's software solutions, such as AirView and myAir, facilitate remote monitoring and management of patient outcomes. AirView allows healthcare professionals to remotely monitor and adjust patients' device settings, while myAir, a personalized therapy management app, supports patients with sleep apnea through education, troubleshooting tools, and engagement strategies to improve compliance.
  • U-Sleep Compliance Monitoring - U-Sleep is a solution designed to help home medical equipment (HME) providers streamline their sleep programs by efficiently monitoring patient compliance, an essential factor for successful therapy outcomes.
  • Out-of-Hospital Software Solutions - ResMed provides various software solutions like Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, catering to the business management and caregiving needs of HME providers, pharmacies, senior living facilities, skilled nursing facilities, and hospice organizations. These solutions include business management software, electronic health records, billing, coding services, and analytics, facilitating improved care delivery and operational efficiency.

Contact Information

Address: 9001 Spectrum Center Boulevard
Phone: 858 836 5000